Download the official program HERE.
Sandro Galea, MD, DrPH
Boston University, USA
Making psychiatric epidemiology count: asking the right questions to improve population mental health.
Sandro Galea, a physician and an epidemiologist, is dean and Robert A. Knox Professor at Boston University School of Public Health. He previously held academic and leadership positions at Columbia University, the University of Michigan, and the New York Academy of Medicine. Galea’s scholarship has been at the intersection of social and psychiatric epidemiology, with a focus on the behavioral health consequences of trauma, including firearms. He has published more than 700 scientific journal articles, 50 chapters, and 13 books, and his research has been featured extensively in current periodicals and newspapers. Galea was named one of “Time” magazine’s epidemiology innovators, and has been listed by Thomson Reuters as one of the “World’s Most Influential Scientific Minds.” He is past president of the Society for Epidemiologic Research and an elected member of the National Academy of Medicine and the American Epidemiological Society. Galea has received several lifetime achievement awards for his research, including the Rema Lapouse Award from the American Public Health Association and the Robert S. Laufer, PhD, Memorial Award from the International Society for Traumatic Stress Studies. He is a regular contributor to “Fortune” magazine and has published widely in the lay press, including the “Wall Street Journal,” “Harvard Business Review,” the “Boston Globe,” and “The New York Times.” His research has been cited by these publications as well as BBC, Slate, WBUR, and NPR, among others. At the IFPE 2019 he will deliver us the talk “Making psychiatric epidemiology count: asking the right questions to improve population mental health.”
Johan Ormel, MD, PhD
University of Groningen, The Netherlands
Solving the paradox of more treatment but not less prevalence (explanations and remedies)
Johan Ormel is Professor of Psychiatric Epidemiology at the University of Groningen, the Netherlands. With a profitable scientific production – nearly 500 indexed publications and an h-index of 85 – he was founder and director of the Tracking Individuals Lifes Survey (TRAILS), one of the most important epidemiological studies on mental health of adolescents in the world. Having (co-) supervised 50 PhD thesis over more than 30 years of career, Prof. Ormel is author of several keynote papers such as “Synchrony of change in depression and disability. What next?”(2000), “Disability and treatment of mental and physical disorders accross the world: Results from The Who World Mental Health Surveys”(2008), and “Why Personality and Psychopathology are Correlated: a developmental perspective is a first step but more is needed”(2014).
At our 17th IFPE Congress in 2019 in São Paulo he will deliver the provocative lecture “Solving the paradox of more treatment but not less prevalence (explanations and remedies)”.
Don’t miss it!
Andreas Heinz, Ph.D.
Humboldt University Berlin, Germany
Human rights in psychiatry – implications of the UN Convention on the Rights of Persons with Disabilities
As one of the most renowned researchers in Europe and Worldwide, Prof. Andreas Heinz is dedicated to the study on neurobiological and sociocultural factors determining mental health. He is currently Director and Chair of the Department of Psychiatry and Psychotherapy of Charité, Humboldt University Berlin (since 2002). With a Researchgate score of 53.21 and an h-index of 87, Prof. Heinz is one of the most prolific and influential researchers in the field. We are pleased to announce his presence at the IFPE 2019 São Paulo, delivering the very important lecture entitled “Human rights in psychiatry – implications of the UN Convention on the Rights of Persons with Disabilities”. Don’t miss the chance!
Nikolas Rose, Ph.D.
King’s College London, England
What is the future of psychiatry?
The Introduction to the recent Report of the Lancet Commission on the Future of Psychiatry states: “Psychiatry has always been a medical discipline, but was this development inevitable, and will it always be this way?” (Bhugra et al., 2017: 776). In this talk Prof. Rose will consider the possibility that psychiatry could become a different kind of medicine. In this future, psychiatry would embrace the approach of social medicine, identifying and addressing the forms of social adversity that give rise to mental distress, understanding the pathways by which adversity acts on brain, mind and body, advocating for changes in the organization of practices ranging from the organization of school and work to the priorities of urban planning. This would involve a transformation in the power relations that have always characterised this form of expert knowledge. It would require a different and non-reductionist neuroscience of mental distress, a different approach to psychiatric diagnosis, a different role for mental health professionals and a new status for the knowledge and expertise of those who experience mental distress. Prof. Rose will suggest that we are at a potential turning point where such a future not just possible but increasingly seen as necessary by many working in the field of mental health, and I will outline the possibilities for a new, different and political progressive psychiatric biopolitics.
Cheryl Corcoran, MD
Icahn School of Medicine at Mount Sinai, NY, USA
Can we prevent psychosis?
Dr. Corcoran is Associate Professor and Program Leader in Psychosis Risk at the Icahn School of Medicine at Mount Sinai, New You. Her research focus has been to identify biomarkers of risk and illness progression in schizophrenia: in collaboration, she has identified increased limbic activation, cognitive disorganization, social cognitive deficits, and sensory processing abnormalities as risk biomarkers for schizophrenia. She is now utilizing the tools of cognitive neuroscience, including neural imaging, EEG and brain stimulation, and new tools like speech analysis, to more fully characterize these deficits, such that early intervention strategies can be developed and implemented. Dr. Corcoran has also studied the role of environment in schizophrenia risk and onset, including stress and cannabis use, as well as stigma and recovery related to schizophrenia. At the IFPE 2019 she will address the question “Can we prevent psychosis?” showing the latest findings in the field.
Wulf Rössler, MD, MSc
University Medicine Berlin, Germany
The stigma of mental illness – End of the story?
Prof. Wulf Rössler is Senior Professor at the Charité, University Medicine Berlin, Germany. Prof. Rössler was Full Professor of Clinical and Social Psychiatry at the University of Zurich and Head of the Department of General and Social Psychiatry. He was the President of the Cantonal Drug Commission until 2009. Between 2009 and 2016 he was the Director of the Zurich Program for Sustainable Development of Psychiatric Services, a comprehensive research program with seven large-scale projects covering psychiatric epidemiology and mental health services research. In 2009-2017 he was a fellow of the Collegium Helveticum, a joint research institute between the University of Zurich and the Swiss Federal Institute of Technology Zurich (ETH), where he took responsibility for several research projects. He was Senior Professor at the University of Lüneburg (Germany)(2013-2016), where he was also appointed as the Head of a Health Services Research Team in the framework oft the Innovation Incubator, a large-scale research programme funded by the EU (2010-2015). Currently he is President of the International Federation of Psychiatric Epidemiology. Among many achievements, Prof. Rössler has published numerous chapters in textbooks and also published as an editor several textbooks covering topics from Emergency Psychiatry, Psychiatric Rehabilitation to Art Therapy and Social Psychiatry. Has over 450 entries in Pubmed, and over 14,000 citations (Researchgate). With this distinguished curriculum, Prof. Rössler will deliver us the speech “The Stigma of Mental Illness – End of the Story?”
Mirella Ruggeri, MD, PhD
University of Verona, Italy
Community Psychiatry in Italy and in the Global Mental Health Context: the Strenghts and the Challenges
Mirella Ruggeri is MD, specialized in Psychiatry, and PhD. Appointed as Full Professor in Psychiatry in 2004 at the University of Verona, where she is currently Head of the Section of Psychiatry (October 2013-present), Director of the Specialization School in Psychiatry (2011–present) and Director of the South-Verona Community Mental Health Service, which provides comprehensive and integrated psychiatric care (prevention, therapy and rehabilitation) for the adult population living in the South-Verona catchment area.
Her main fields of interest include epidemiological and social psychiatry, mental health service evaluation, assessment of outcome of psychiatric disorders. She conducted several research projects at European and National level in the fields of Service Evalutation, Effectiveness of psychosocial interventions, Neurobiology, Clinical Psychopharmacology and Liaison Psychiatry.
She has been Appointed as Chairperson of the European Network for Mental Health Service Evaluation (ENMESH) (acting from May 2008 till October 2015), and currently Vice-President of the International Federation of Psychiatric Epidemiology (IFPE) (October 2017-present).
Among other projects she developed the South Verona Outcome Project, the EPSILON Study of Schizophrenia, and the GET UP Research Program on early Psychosis. With over 300 publications and 5000 citations (ISI Web of Knowledge), Prof. Ruggeri will share her great expertise in public mental healthcare with the lecture “Community Psychiatry in Italy and in the global mental health context: the strenghts and the challenges”.
James Kirkbride, MD, PhD
University College London, UK
Psychoses sans Frontieres: towards an interdisciplinary understanding of psychosis risk amongst migrants and their descendants
Prof. James Kirkbride is a Henry Dale Fellow (Welcome Trust and Royal Society) and Reader in Epidemiology in the Division of Psychiatry at University College London. He is currently running two major epidemiological studies of first episode psychosis: the Social Epidemiology of Psychoses in East Anglia study (SEPEA) and the Cambridgeshire Centre of the European Network of Schizophrenia Networks studying Gene-Environment Interactions (EU-GEI). With a Web of Knowledge h-index of 27, he will share his great expertise in psychosis by delivering us the lecture “Psychoses sans Frontieres: towards an interdisciplinary understanding of psychosis risk amongst migrants and their descendants”. We are happy to welcome this outstanding researcher to the IFPE 2019 Sao Paulo!
Alexander Moreira-Almeida, MD, PhD
Universidade Federal de Juiz de Fora, Brazil
Exploring psychotic experiences in non-clinical population: the case of spiritual experiences
Prof. Alexander Moreira-Almeida is currently Chair of the Section on Religion, Spirituality and Psychiatry of the World Psychiatric Association (WPA) and led the recent publication of the WPA Position Statement on Spirituality and Religion in Psychiatry. He is one of the world leaders in the scientific investigation of spirituality and mental health. One of his main research fields is on clinical and neuroimaging studies of spiritual experiences, especially their similarities and distinctions from psychotic symptoms. Among his publications are “Differential diagnosis between non-pathological psychotic and spiritual experiences and mental disorders” (Revista Brasileira de Psiquiatria, 2011) and “Neural correlates of psychotic-like experiences during spiritual-trance state” (Psychiatry Research: Neuroimaging). We are pleased to announce his presence at the IFPE 2019 with the conference “Exploring psychotic experiences in non-clinical population: the case of spiritual experiences”.